Global Biologics and Biosimilars Market by Manufacturers, Regions, Type and Application, Forecast


Posted December 16, 2016 by globalinforesearchma

"A biologic is a medicine made using a living system, and historically this was often an animal.
 
"A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.
A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires."

Published by: GIR (GlobalInfoResearch)
Catalog: Pharma & Healthcare
Publishing Date: Dec 2016
Single User License: USD 3480
Corporate Users License: USD 4680
Delivery time: 24 hours
Pages: 110
Tables and Figures: 138

Full information :[url]http://www.globalinforesearch.com/goods.php?id=2554[url]

Scope of the Report:

This report focuses on the Biologics and Biosimilars in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America, Middle East and Africa

Market Segment by Type, covers
Antibody
Hormone
Growth Factors
Other

Market Segment by Applications, can be divided into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other

There are 13 Chapters to deeply display the global Biologics and Biosimilars market.

Chapter 1, to describe Biologics and Biosimilars Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Biologics and Biosimilars, with sales, revenue, and price of Biologics and Biosimilars, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Biologics and Biosimilars, for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 11, Biologics and Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;

Chapter 12 and 13, to describe Biologics and Biosimilars sales channel, distributors, traders, dealers, appendix and data source.


Betty
Sales Director
E-mail:[email protected]
Tel: HK:00852-58197708 USA:0013479661888
Add: Room 1902 Two International Finance Centre 8 Finance Street, Central Hong Kong
Website: http://www.globalinforesearch.com/goods_all.php
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Globalinforesearch
Country Hong Kong SAR
Categories Business , Reports , Research
Last Updated December 16, 2016